Search results
Results From The WOW.Com Content Network
A study published in April 2021 by researchers from the COVID-19 Genomics United Kingdom Consortium, the AMPHEUS Project, and the Oxford COVID-19 Vaccine Trial Group indicated the Oxford–AstraZeneca vaccine showed somewhat reduced efficacy against infection with the Alpha variant (lineage B.1.1.7), with 70.4% efficacy in absolute terms ...
AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) (AZ) is a British-Swedish [2] [3] [4] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. [5]
Additional sites, including large venues such as sports stadia, entered the programme from 11 January 2021, with seven mass vaccination centres opening in England initially and seven in Wales. [12] New guidance for allergy sufferers, antibody tests, new variants of SARS-CoV-2 (B.1.1.7 and B.1.617) and the use of the AstraZeneca vaccine in ...
For example, AstraZeneca and GlaxoSmithKline, although headquartered in the United Kingdom, have activities in numerous other countries, and Johnson & Johnson and Pfizer are both headquartered in the United States and have activities in many countries worldwide.
British finance minister Rachel Reeves wants to reduce state provisions to the company's vaccine centre, which will cut the pledge made by the previous administration from about 90 million pounds ...
Drug Discovery company C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca plc (NASDAQ: AZN) worth up to $402 million for its NRF2 Activator program.
(Reuters) -Britain's competition regulator is reviewing AstraZeneca's planned $39 billion takeover of U.S.-based Alexion on whether it could reduce competition in Britain or other markets. The UK ...
The United Kingdom pre-ordered 100 million doses of the Oxford–AstraZeneca COVID-19 vaccine candidate by May 2020, [7] through AstraZeneca UK Limited. [8] While in parallel offering UK taxpayer-funded grants to vaccine manufacturers, in the UK and EU, to increase capacity, including approximately £21 million of UK funding for the Halix plant ...